Fair Value Distribution — percentile bands
19.6% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
6.5%/yr
±7.3% · revenue growth to justify current price
FCF-Based Reverse DCF
1.2%/yr
±2.9% · FCF growth to justify current price
THE GAP
Market pricing margin expansion or capex normalization
Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.
Sign in to unlockCorteva, Inc.
No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.
No analysis yet
No analysis yet
CTVA 2025 10-K: Planned separation into Seed and Crop Protection. Seed strong with dominant Enlist E3; Crop Protection faces margin pressure from patents/generics. Regulatory (EPA), geopolitical (Chin...